These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 17540602

  • 1. Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal.
    Flan B, Arrabal S.
    Transfus Clin Biol; 2007 May; 14(1):51-62. PubMed ID: 17540602
    [Abstract] [Full Text] [Related]

  • 2. Current strategies to prevent transmission of prions by human plasma derivatives.
    Burnouf T, Padilla A.
    Transfus Clin Biol; 2006 Nov; 13(5):320-8. PubMed ID: 17254822
    [Abstract] [Full Text] [Related]

  • 3. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML, Ludlam CA.
    Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
    [Abstract] [Full Text] [Related]

  • 4. Variant Creutzfeldt-Jakob disease transmission by plasma products: assessing and communicating risk in an era of scientific uncertainty.
    Farrugia A, Ironside JW, Giangrande P.
    Vox Sang; 2005 Nov; 89(4):186-92. PubMed ID: 16262750
    [Abstract] [Full Text] [Related]

  • 5. An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
    Cervia JS, Sowemimo-Coker SO, Ortolano GA, Wilkins K, Schaffer J, Wortham ST.
    Transfus Med Rev; 2006 Jul; 20(3):190-206. PubMed ID: 16787827
    [Abstract] [Full Text] [Related]

  • 6. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA, Turner ML.
    Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
    [Abstract] [Full Text] [Related]

  • 7. Transfusion transmission of human prion diseases.
    Zou S, Fang CT, Schonberger LB.
    Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
    [Abstract] [Full Text] [Related]

  • 8. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products.
    Ironside JW, Head MW.
    Haemophilia; 2004 Oct; 10 Suppl 4():64-9. PubMed ID: 15479374
    [Abstract] [Full Text] [Related]

  • 9. Consensus statement on the bio-safety of urinary-derived gonadotrophins with respect to Creutzfeldt-Jakob disease.
    Balen AH, Lumholtz IB.
    Hum Reprod; 2005 Nov; 20(11):2994-9. PubMed ID: 16055457
    [Abstract] [Full Text] [Related]

  • 10. ['Variant of Creutzfeldt-Jacob disease and blood transfusion'; report of the Dutch Health Council].
    van Aken WG.
    Ned Tijdschr Geneeskd; 2001 Jul 28; 145(30):1444-7. PubMed ID: 11503311
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The risk of prion contamination through the transfusion of cellular products].
    Lefrère JJ.
    Transfus Clin Biol; 2007 May 28; 14(1):25-34. PubMed ID: 17499536
    [Abstract] [Full Text] [Related]

  • 13. TSE clearance during plasma products separation process by Gradiflow(TM).
    Wang K, Johnson A, Obradovic M, Anderson G, Maclean C, Nair H.
    Biologicals; 2005 Jun 28; 33(2):87-94. PubMed ID: 15939286
    [Abstract] [Full Text] [Related]

  • 14. Prions and transfusion medicine.
    Budka H.
    Vox Sang; 2000 Jun 28; 78 Suppl 2():231-8. PubMed ID: 10938959
    [Abstract] [Full Text] [Related]

  • 15. Risk of transmission of Creutzfeldt-Jakob disease via blood and blood products. The French risk-analysis over the last 15 years.
    Martin M, Trouvin JH.
    Transfus Clin Biol; 2013 Sep 28; 20(4):398-404. PubMed ID: 23910008
    [Abstract] [Full Text] [Related]

  • 16. The risk of accidental transmission of transmissible spongiform encephalopathy: identification of emerging issues.
    Ramasamy I.
    Public Health; 2004 Sep 28; 118(6):409-20. PubMed ID: 15313594
    [Abstract] [Full Text] [Related]

  • 17. From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France.
    Lefrère JJ, Hewitt P.
    Transfusion; 2009 Apr 28; 49(4):797-812. PubMed ID: 19170997
    [Abstract] [Full Text] [Related]

  • 18. Clearance of prions during plasma protein manufacture.
    Burdick MD, Pifat DY, Petteway SR, Cai K.
    Transfus Med Rev; 2006 Jan 28; 20(1):57-62. PubMed ID: 16373188
    [Abstract] [Full Text] [Related]

  • 19. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
    Chohan G, Llewelyn C, Mackenzie J, Cousens S, Kennedy A, Will R, Hewitt P.
    Transfusion; 2010 May 28; 50(5):1003-6. PubMed ID: 20230536
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.